The United States Food and Drug Administration (FDA) has approved a twice-a-year injectable drug to be used for HIV ...

A recent study discovered that an inexpensive HIV drug could be effective for diabetic people by reversing a complication ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

The recent FDA approval of lenacapavir is encouraging in its promise of long-term HIV prevention but might not be available for the vast majority of people in the US.

And other biotech news brought to you by The Readout.

Amy Grant meeting Bono at Charlie Peacock's house in 2002 to discuss the HIV/AIDS crisis. The queen of Christian pop is ...

The visit also served as an opportunity to explore how UNAIDS can support South Africa’s G20 Presidency and the country’s ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...

Discover a study that has highlighted the potential importance of dietitian-led interventions in liver health. Learn more.

President Donald Trump announced he is ending funding for a national youth suicide prevention hotline that served over 1.3 million people.